Contract HT942525C0035
Hemoglobin Oxygen Therapeutics Llc · Department Of Defense · July 10, 2025
Hemoglobin Oxygen Therapeutics Llc was awarded a federal contract by Department Of Defense (Defense Health Agency) on July 10, 2025 for $2.11 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Souderton, PA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 15, 2025. If all options are exercised, the contract could reach $12.53 million.
Contract details
- PIID
- HT942525C0035
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Souderton, PA
- First action
- July 10, 2025
- Latest action
- December 15, 2025
Description
CANINE OXYGEN CARRIER MANUFACTURING RESTORATION AND REGULATORY ACTIVITIES
Modification timeline
-
December 15, 2025Mod P00003 · Funding Only Action$9.56M
-
August 25, 2025Mod P00002 · Funding Only Action$8.74M
-
July 10, 2025Mod P00001 · Supplemental Agreement For Work Within Scope$8.74M
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $2.75B |
| 2 | California Institute Of Technology | 240 | $979.40M |
| 3 | The Johns Hopkins University Applied Physics Laboratory Llc | 204 | $482.74M |
| 4 | Lockheed Martin Corporation | 4 | $461.91M |
| 5 | Lockheed Martin Corp | 9 | $317.27M |
| 6 | The Aerospace Corporation | 85 | $308.18M |
| 7 | Fermi Forward Discovery Group, Llc | 1 | $289.92M |
| 8 | Lockheed Martin Corp | 7 | $285.45M |
| 9 | Amentum Technology, Inc. | 4 | $253.24M |
| 10 | The Mitre Corporation | 50 | $222.51M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HT942525C0035?
Contract HT942525C0035 is a federal contract awarded to Hemoglobin Oxygen Therapeutics Llc by Department Of Defense on July 10, 2025 for $2.11 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract HT942525C0035?
Hemoglobin Oxygen Therapeutics Llc won contract HT942525C0035 from Department Of Defense.
How much is contract HT942525C0035 worth?
Contract HT942525C0035 has obligated $2.11 million to date, with a total potential value of $12.53 million if all options are exercised.